- Acquired Intelligent Fingerprinting Limited and its proprietary drugs of abuse screening technology - - Announced new additions to Board of Directors and name change to Intelligent Bio Solutions Inc. - - Company to host conference call & webcast today at 4:30 p.m. ET - NEW YORK , Nov.

- Can now test 1,000 employees across six sites as required, with each test always taking only ten minutes - NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company developing non-invasive, real-time diagnostic testing for

- Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European Aviation Authority regulations - NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company developing non-invasive,

- Company to Host Conference Call & Webcast at 4:30 p.m. ET - NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, today announced that it will release

- Company to Host Conference Call & Webcast at 4:30 p.m. ET - NEW YORK , Nov. 02, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, today announced that it will release

Goldstar Transport to Remove Urine Testing for Sweat Based Technology NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, today announced that Goldstar

- Name change to more closely reflect firm’s expanding portfolio of intelligent, efficient, convenient and practical noninvasive and drug testing technologies and products - - Harry Simeonidis appointed as Chief Executive Officer - - David Jenkins and Jason Isenberg appointed to Board of Directors

The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia , United Kingdom and the US NEW YORK , Oct. 04, 2022 (GLOBE NEWSWIRE) --  GBS Inc.

- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the time-course of

Company to Host Conference Call & Webcast at 4:30 p.m. ET NEW YORK , Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it